Acurx Pharmaceuticals, Inc. (ACXP) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ACXP Revenue Growth
ACXP Revenue Analysis (2019–2025)
As of May 8, 2026, Acurx Pharmaceuticals, Inc. (ACXP) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, ACXP's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ACIU (-86.9% YoY), LPSN (-22.0% YoY), and NAOV (-18.4% YoY). Compare ACXP vs ACIU →
ACXP Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ACXPCurrent | $0 | - | - | - | |
 ACIU | $4M | -86.9% | -25.4% | -1927.3% | |
 LPSN | $244M | -22.0% | -7.8% | -9.6% | |
 NAOV | $3M | -18.4% | +37.0% | -140.0% | |
 PHAT | $175M | +150.3% | - | -91.4% |
ACXP Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $0 | - |
| 2024 | $0 | - | $0 | - | $-14,103,103 | - |
| 2023 | $0 | - | $0 | - | $-14,577,768 | - |
| 2022 | $0 | - | $0 | - | $-12,092,776 | - |
| 2021 | $0 | - | $0 | - | $-12,814,200 | - |
| 2020 | $0 | - | $0 | - | $-4,600,038 | - |
| 2019 | $0 | - | $0 | - | $-5,931,253 | - |
See ACXP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ACXP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ACXP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonACXP — Frequently Asked Questions
Quick answers to the most common questions about buying ACXP stock.
Is ACXP's revenue growth accelerating or slowing?
ACXP TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ACXP's long-term revenue growth rate?
Acurx Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ACXP's revenue distributed by segment?
ACXP reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.